Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk factors associated with resistance to a short-acting selective beta-1 blocker under general anesthesia
jRCT1030250035Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of landiolol in tachyarrhythmia, sponsored by Ono Pharmaceutical. Primary endpoint: Change in heart rate after landiolol bolus. Started Jan 2015; status: completed.
02
Drugs
landiolol
03
Conditions
tachyarrhythmia
Beyond the preview
Go deeper on jRCT1030250035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030250035.